ACS RX ROCKET TM AND ACS AVENGER CORONARY DILATATION CAHTETERS
FDA premarket approval P810046/S179 · decided 1997-11-07
Approval details
- PMA number
- P810046
- Supplement
- S179
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- ACS RX ROCKET TM AND ACS AVENGER CORONARY DILATATION CAHTETERS
- Generic name
- Catheters, transluminal coronary angioplasty, percutaneous
- Applicant
- Advanced Cardiovascular Systems, Inc.
- Date received
- 1997-06-19
- Decision date
- 1997-11-07
- Days to decision
- 141 days
- Decision code
- APPR
- Product code
- LOX
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Temecula, CA
- Statement
- Approval for the ACS RX Rocket(TM) and ACS Avenger(TM) Coronary Dilatation Catheters. The device is indicated for: 1)balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis for ht epurpose of improving myocardial perfusion; and 2) balloon dilatation of a coronary artery occlusion for the purpose of restoring coronary flow in patients with S-T segment elevation myocardial infarction.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.